| 1 |
33352197 | Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes. | 2021 Feb |
1 |
| 2 |
34577576 | Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling. | 2021 Aug 29 |
1 |
| 3 |
30782019 | Rapamycin attenuates articular cartilage degeneration by inhibiting β-catenin in a murine model of osteoarthritis. | 2019 Sep |
1 |
| 4 |
28560583 | Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab. | 2017 Dec |
2 |
| 5 |
31966350 | Anti-angiogenic effect of rapamycin in mouse oxygen-induced retinopathy is mediated through suppression of HIF-1alpha/VEGF pathway. | 2017 |
3 |
| 6 |
27035650 | Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation. | 2016 Jun |
3 |
| 7 |
27138352 | Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury. | 2016 Jun 21 |
1 |
| 8 |
27347023 | Effect of rapamycin on endometriosis in mice. | 2016 Jul |
1 |
| 9 |
23476113 | Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells. | 2013 |
2 |
| 10 |
22343319 | Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. | 2012 Aug 28 |
1 |
| 11 |
22828505 | Constitutive activation of the mTOR signaling pathway within the normal glomerulus. | 2012 Aug 24 |
1 |
| 12 |
22192404 | Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. | 2011 Dec 22 |
1 |
| 13 |
21200439 | mTORC1-S6K activation by endotoxin contributes to cytokine up-regulation and early lethality in animals. | 2010 Dec 21 |
1 |
| 14 |
19002496 | Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. | 2009 May |
1 |
| 15 |
19443844 | Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. | 2009 Aug |
1 |
| 16 |
19554030 | Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. | 2009 Oct |
1 |
| 17 |
20092777 | [Effects of Rapamycin on angiogenesis and tumor progression in human hepatocellular carcinoma implantation mice]. | 2009 Sep 15 |
4 |
| 18 |
18480312 | Differential effects of rapamycin in anti-GBM glomerulonephritis. | 2008 Aug |
1 |
| 19 |
18564143 | Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice. | 2008 |
1 |
| 20 |
19018001 | CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. | 2008 Dec 1 |
1 |
| 21 |
17589348 | Sirolimus toxicity and vascular endothelial growth factor release from islet and renal cell lines. | 2007 Jun 27 |
2 |
| 22 |
15671269 | Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. | 2005 Feb |
2 |
| 23 |
15701277 | Mechanisms of action of rapamycin in gliomas. | 2005 Jan |
3 |
| 24 |
15958580 | Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. | 2005 Jun 15 |
1 |
| 25 |
16895664 | [Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs]. | 2005 Mar |
1 |
| 26 |
15634505 | [Relationship of hypoxia-inducible factor-1alpha expression and vascular endothelial growth factor in SKOV-3 ovarian cancer model]. | 2004 Nov |
1 |
| 27 |
12631072 | Rapamycin is an effective inhibitor of human renal cancer metastasis. | 2003 Mar |
1 |
| 28 |
14500340 | Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. | 2003 Sep 1 |
1 |
| 29 |
11255225 | Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. | 2001 |
1 |